Expand Your Group Practice with Ketamine-Assisted Psychotherapy About Journey Clinical: We are facing a mental health crisis with 100M+ people suffering from depression and anxiety in the US, and legacy treatments don’t always work. Our mission is to expand access to safe, clinically-effective, transformative Psychedelic-Assisted Psychotherapies, starting with Ketamine-Assisted Psychotherapy (KAP). Ketamine-Assisted Psychotherapy (KAP) is the supervised use of ketamine as an adjunct to psychotherapy. Robust clinical evidence supports the efficacy of KAP for “a wide variety of psychiatric diagnoses and human difficulties, significantly diminishing depression, anxiety and PTSD” (Dore et al, 2019). A growing number of therapy practices around the country are seeking access to Ketamine-Assisted Psychotherapy (KAP) for their clients ; but do not have a relationship with KAP-trained prescribers, or the tools they need to effectively implement KAP into their practice. Journey Clinical has
